CEO
Polypharmakos
The startup develops antimicrobial actives derived from plants and fungi to combat the global antimicrobial resistance crisis. Their chemical-free solutions provide effective treatment options for the pharmaceutical, consumer health, and agri-tech sectors.
- Biotechnology
Updated 11 months ago
Funding
Raised to date
$740KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
$617K across 1 disclosed round
CEP$617K · Seed
Announced Jan 2017
Disclosed cumulative: $617K
Reported total $740K
Incomplete round history. $123K of the $740K reported total isn’t matched to a known round.
RoundDateAmountValuationInvestors
Founders
Product
Features
- The startup develops antimicrobial actives derived from plants and fungi to combat the global antimicrobial resistance crisis. Their chemical-free solutions provide effective treatment options for the pharmaceutical, consumer health, and agri-tech sectors.